If you are fed up of your irritating bowel syndrome with constipation (IBS-C), then the U. S. Food and Drug Administration has today approved a drug for fleeing you from this continual problem.
Linzess (linaclotide), is the drug that according to FDA is ideal for treating chronic idiopathic constipation and all other kinds of bowel syndrome issues in adults.
According to the estimates of National Institutes of Health, today around 63 million people are affected by chronic constipation. All those individuals who experience constant constipation and no standard treatment suit them are defined in the list of chronic idiopathic constipation.
Apart from this, today around 15.3 million people are troubled by IBS –C. It is a condition, when there is pain in abdominal and the sufferer experience hard or lumpy stools at least 25% of the times and there is loose or watery stool less than 25% of the time.
To get rid from these problems, the sufferer has to take one capsule of Linzess a day and that too empty stomach. For next 30 minutes at least he is not recommended to take his first meal.
By following this treatment regularly, he will soon get relieved from constipation as his bowel movements would occur more frequently. In case of IBS-C, abdominal pain will also be treated.
US Business News
New Zealand News
- After Suspected Botulism, CFIA Warns People
- Health Care Education Necessary for the Future of Province: Analysts
- B.C. Government Grants $700,000 for Managing Facial Deformities
- Michelle Shocked delivers hate speech about homosexuality at her gig
- Guess who Justin Bieber got burned by?!! His ex-girlfriend Selena Gomez